Aprogen Pharmaceuticals Inc (003060) — Cash Flow Quality Index
Aprogen Pharmaceuticals Inc (003060) has a Cash Flow Quality Index of -13.36x as of March 2023. Operating cash flow of ₩-14.74 Billion is below net income of ₩1.10 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Aprogen Pharmaceuticals Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Aprogen Pharmaceuticals Inc Cash Flow Quality Index (2015–2022)
Historical Cash Flow Quality Index for Aprogen Pharmaceuticals Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Aprogen Pharmaceuticals Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Aprogen Pharmaceuticals Inc (2015–2022)
Year-by-year earnings quality comparison for Aprogen Pharmaceuticals Inc. For live market cap and the full company financial profile, see Aprogen Pharmaceuticals Inc (003060) market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 3.28x | ₩25.73 Billion | ₩7.84 Billion | ▲ +527.2% |
| 2021 | -0.77x | ₩-6.23 Billion | ₩8.10 Billion | ▼ -206.9% |
| 2020 | 0.72x | ₩8.09 Billion | ₩11.25 Billion | ▲ +7.4% |
| 2015 | 0.67x | ₩1.85 Billion | ₩2.76 Billion | — |